SGO Annual Meeting - 17 mins
Articles from: OncLive
Mashup Score:1
OncLiveDr Zonder on the Expansion of Targeted Therapies in R/R Multiple Myeloma - 38 mins
Mashup Score:1
Jeffery Zonder, MD, discusses the need for expanding the armamentarium of targeted therapies for patients with relapsed/refractory multiple...
-
WATCH: Jeffery Zonder, MD, discusses the need for expanding the armamentarium of targeted therapies for patients with relapsed/refractory multiple myeloma. @karmanoscancer #mmsm https://t.co/bpDWIAZa7F - view on twitter
More coverage:
#mmsm
Amandeep Godara, MBBS, discusses the current treatment strategies following first relapse for patients with multiple...
-
Amandeep Godara, MBBS, of @huntsmancancer, discusses the current treatment strategies following first relapse for patients with multiple myeloma. #mmsm https://t.co/jYNpBRPRnt https://t.co/jYNpBRPRnt - view on twitter
More coverage:
#mmsm
SGO Annual Meeting - 39 mins
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia...
-
Hear Mary Katherine Montes de Oca, MD, of @DukeU preview research presented at #SGOMtg on cryocompression to reduce neuropathy in gynecologic oncology, and go to our site for more conference coverage! @SGO_org #gyncsm https://t.co/PphtLY4aZb https://t.co/PphtLY4aZb - view on twitter
SGO Annual Meeting - 60 mins
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia...
-
Hear @RyanKahnMD1 of @MSKCancerCenter preview findings with oncolytic immunotherapy in ovarian cancer mouse models, and check out our site for more coverage from #SGOMtg! @SGO_org #gyncsm https://t.co/od8z5TF2lc https://t.co/od8z5TF2lc - view on twitter
Mashup Score:1
OncLiveSGO Annual Meeting - 1 hour
Mashup Score:1
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia...
-
Thank you to Burak Zeybek, MD, of @UFHealth, for chatting with us about exciting takeaways from #SGOMtg! Check out our site for more exlcusive conference coverage! @SGO_org #gyncsm https://t.co/HgssndHIOq https://t.co/HgssndHIOq - view on twitter
Maya Khalil, MD, discusses key clinical trial updates on the use of nivolumab and ipilimumab with or without chemotherapy in non–small cell lung...
-
WATCH: Maya Khalil, MD, of @ONealCancerUAB, discusses key clinical trial updates on the use of nivolumab and ipilimumab with or without chemotherapy in non–small cell lung cancer. #lcsm https://t.co/ucWZplOFl6 - view on twitter
More coverage:
#lcsm
SGO Annual Meeting - 2 hours
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia...
-
Thank you to @ShannonWestin, of @MDAndersonNews, who joined us at #SGOMtg to talk about the SOLAR trial of selumetinib and olaparaib in ovarian cancer! Check our site for more updates from day 2 of the meeting! @SGO_org #gyncsm https://t.co/KS878hJJO4 https://t.co/KS878hJJO4 - view on twitter
SGO Annual Meeting - 2 hours
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia...
-
Thank you to Liat Hogen, MD, of @UofT and @thePMCF, for chatting with us during #SGOMtg about cytoreductive surgery in ovarian cancer! Check out our site for more meeting insights! @SGO_org #gyncsm https://t.co/7MxD3sAiLy https://t.co/7MxD3sAiLy - view on twitter
In this episode of ‘How This is Building Me,’ Camidge sits down with Jalal to discuss her transition from life in Jordan to Indianapolis,...
-
In this episode of #OncLiveOnAir: ‘How This is Building Me,’ Dr Camidge & Jalal discuss Jalal's transition from life in Jordan to Indiana, the realities of being a mother in medicine, transparency in academia, and more. @IUMedSchool @CUAnschutz #oncology https://t.co/QIqg6gkesH https://t.co/QIqg6gkesH - view on twitter
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia...
Hear @MirzaCPH, of @Rigshospitalet, preview presentation details about the RUBY trial of dostarlimab plus chemotherapy in endometrial cancer, and check out our site for more updates from #SGOMtg! @SGO_org #gyncsm https://t.co/vf2VX1JFS0 https://t.co/vf2VX1JFS0 - view on twitter